ArticlePharmaceuticals (Basel, Switzerland)2019

Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling.

Naoyuki Nishiya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.